New antimalarial drug leads targeting multiple species and life cycle stages
New antimalarial drug leads targeting multiple species and life cycle stages
针对多个物种和生命周期阶段的新抗疟药物先导化合物
批准号：
nhmrc : GNT1142875
负责人：
Dr Andrew Riches
金额：
$81.85万
依托单位：
依托单位国家：
澳大利亚
项目类别：
Project Grants
财政年份：
2018
资助国家：
澳大利亚
项目状态：
已结题
起止时间：
2018-01-01 至 --
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Malaria causes ~200 million clinical cases and >430,000 deaths annually. Prevention and treatment relies on drugs, however malaria parasite drug resistance is an enormous problem. To address this issue, and aim towards eliminating malaria, we need to develop new drugs. This project addresses this important health need by investigating the ability of new chemical compounds, developed at CSIRO, to kill human-infecting malaria parasites during different parts of their complicated lifecycles.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
